<scp>PP2A</scp> methylesterase <scp>PME</scp> ‐1 suppresses anoikis and is associated with therapy relapse of <scp> <i>PTEN</i> </scp> ‐deficient prostate cancers-Reference-Cited by-同舟云学术

PP2A methylesterase PME ‐1 suppresses anoikis and is associated with therapy relapse of PTEN ‐deficient prostate cancers

Published:2023-04-18 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Aakula Anna¹,Isomursu Aleksi¹,Rupp Christian¹,Erickson Andrew²,Gupta Nikhil¹,Kauko Otto¹,Shah Pragya³,Padzik Artur¹,Pokharel Yuba Raj¹,Kaur Amanpreet¹,Li Song‐Ping⁴,Trotman Lloyd⁵,Taimen Pekka⁴⁶,Rannikko Antti⁷,Lammerding Jan³,Paatero Ilkka¹,Mirtti Tuomas²,Ivaska Johanna¹⁸⁹¹⁰^ORCID,Westermarck Jukka¹⁴⁹^ORCID

Affiliation:

1. Turku Bioscience Centre University of Turku and Åbo Akademi University Finland

2. HUSLAB Laboratory Services, Helsinki University Hospital Medicum and Institute for Molecular Medicine Finland FIMM University of Helsinki Finland

3. Weill Institute for Cell and Molecular Biology & Meinig School of Biomedical Engineering Cornell University Ithaca NY USA

4. Institute of Biomedicine University of Turku Finland

5. Cold Spring Harbor Laboratory NY USA

6. Department of Pathology Turku University Hospital Finland

7. Department of Urology Helsinki University Central Hospital Finland

8. Department of Life Technology University of Turku Finland

9. InFLAMES Research Flagship Center University of Turku Finland

10. Foundation for the Finnish Cancer Institute Helsinki Finland

Funder